Takeda Pharmaceutical Company Limited TAK
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.84B | 3.74B | 4.18B | 4.60B | 2.43B |
| Total Receivables | 5.88B | 5.51B | 4.83B | 4.75B | 4.71B |
| Inventory | 8.90B | 8.78B | 8.98B | 8.78B | 8.60B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.76B | 1.40B | 1.89B | 1.60B | 1.68B |
| Total Current Assets | 19.38B | 19.44B | 19.88B | 19.74B | 17.42B |
|
|
|||||
| Total Current Assets | 19.38B | 19.44B | 19.88B | 19.74B | 17.42B |
| Net Property, Plant & Equipment | 13.18B | 13.34B | 13.29B | 13.41B | 13.56B |
| Long-term Investments | 36.22B | 36.53B | 36.69B | 36.70B | 36.71B |
| Goodwill | 36.22B | 36.53B | 36.69B | 36.70B | 36.71B |
| Total Other Intangibles | 20.86B | 21.50B | 22.42B | 22.29B | 23.72B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.66B | 6.69B | 5.93B | 5.58B | 5.59B |
| Total Assets | 96.36B | 97.55B | 98.28B | 97.78B | 97.07B |
|
|
|||||
| Total Accounts Payable | 2.75B | 2.04B | 2.98B | 2.97B | 2.92B |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 163.50K | -- | -- | 2.05B |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.20B | 3.63B | 3.72B | 1.99B | 520.14M |
| Total Finance Division Other Current Liabilities | 11.06B | 12.14B | 9.95B | 9.51B | 9.55B |
| Total Other Current Liabilities | 11.06B | 12.14B | 9.95B | 9.51B | 9.55B |
| Total Current Liabilities | 17.01B | 17.81B | 16.65B | 14.46B | 15.04B |
|
|
|||||
| Total Current Liabilities | 17.01B | 17.81B | 16.65B | 14.46B | 15.04B |
| Long-Term Debt | 27.19B | 27.48B | 27.24B | 29.40B | 28.66B |
| Short-term Debt | -- | 163.50K | -- | -- | 2.05B |
| Capital Leases | 3.67B | 3.33B | 3.63B | 3.69B | 3.71B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.99B | 2.20B | 2.01B | 2.04B | 2.07B |
| Total Liabilities | 49.86B | 50.82B | 49.52B | 49.59B | 49.48B |
|
|
|||||
| Common Stock & APIC | 21.44B | 21.83B | 21.98B | 23.17B | 24.16B |
| Retained Earnings | 4.10B | 4.48B | 6.99B | 7.76B | 8.02B |
| Treasury Stock & Other | 20.95B | 20.41B | 19.78B | 17.25B | 15.41B |
| Total Common Equity | 46.50B | 46.72B | 48.75B | 48.18B | 47.58B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.50B | 46.72B | 48.75B | 48.18B | 47.58B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 6.08M | 7.60M | 7.32M | 6.70M | 6.38M |
| Total Equity | 46.50B | 46.73B | 48.75B | 48.19B | 47.59B |
|
|
|||||